To our knowledge, this is the first reported pre-clinical gene therapy treatment of an established model of the Laron Syndrome (LS), i.e., the GHR−/− or “knockout” mice [18] using an AAV8 vector directing expression of mouse GHR (mGHR) to the liver. Here, GHR is linked to Leigh syndrome.